|Bid||0.00 x 900|
|Ask||191.98 x 2200|
|Day's Range||189.01 - 192.80|
|52 Week Range||118.50 - 224.64|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||14.53|
|Earnings Date||Jul 30, 2020|
|Forward Dividend & Yield||0.04 (0.02%)|
|Ex-Dividend Date||Mar 09, 2020|
|1y Target Est||243.76|
Acquisitions, business streamlining, strong balance sheet, high profitability, clear visibility of earnings growth make Cigna (CI) and attractive bet.
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MGIC Investment (MTG) is poised to grow given its improved premium, solid new business written and strong persistency, partly offset by high cost.
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. We are almost done with the second quarter. Investors decided […]
Is Cigna Corporation (CI) a great pick from the value investor's perspective right now? Read on to know more.
Cigna (CI) could produce exceptional returns because of its solid growth attributes.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna's (CI) collaboration with Priority Health intends to provide improved health outcomes for the Michigan community and out-of-state members of Priority Health.
HealthInvest Partners AB is the investment management company of HealthInvest Small & MicroCap Fund. HealthInvest Partners recently released its April month Investor Letter, a copy of which you can download here. HealthInvest Small & MicroCap Fund rose 9.1% in April, which was broadly in line with its benchmark index. You should check out HealthInvest Partners […]
Priority Health and Cigna (NYSE: CI) today announced they have formed a Strategic Alliance and will partner to make comprehensive health care coverage more affordable and accessible to Michigan employers, their employees and families.
* Insider buying can be an encouraging signal for potential investors. * Some insiders took advantage of a secondary offering last week. * Two chief executives also have stepped up to the buy window.Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit. So insider buying can be an encouraging signal for potential investors, particularly during periods of uncertainty.Insiders continued to add shares despite overall market volatility and economic uncertainty. The following are some of the most noteworthy insider purchases reported in the past week.A director at Axis Capital Holdings Limited (NYSE: AXS) indirectly bought less than 1.35 million shares of this Bermuda-based company at between $38.77 and $42.50 each. That totaled around $55.67 million, and it almost doubled the director's stake.A Fate Therapeutics Inc (NASDAQ: FATE) director indirectly picked up more than 1.41 million shares of this biopharmaceutical company for $28.31 each.That totaled about $40 million and brought the stake to nearly 12.63 million shares.Several insiders at Cannae Holdings Inc (NYSE: CNNE), including President Brent Bickett, took advantage of a secondary offering of $37.50 per share. The more than 248,300 shares of this investment firm scooped up by these insiders totaled more than $9.31 million altogether.An AES Corp (NYSE: AES) director returned and indirectly purchased another 500,000 shares of the Virginia-based electric utility at prices ranging from $12.19 to $12.25 each. That totaled about $6.11 million. The same director bought 500,000 shares in May.Fox Corp (NASDAQ: FOX) CEO Lachlan Murdoch bought more than 101,500 shares last week. At $28.29 per share, that added up to more than $2.87 million. Note that pursuant to a transfer plan, those shares were simultaneously sold to a family trust at the same price.A director at Cigna Corp (NYSE: CI) picked up fewer than 5,500 shares of this Connecticut-based insurer. At an average price of about $187.36 per share, that came to more than $1.02 million. Note that some executives were selling shares earlier in the month.CEO Thomas Greco paid $136.13 each for more than 7,200 Advance Auto Parts, Inc. (NYSE: AAP) shares. That cost him about $991,707 and brought his stake to almost 132,500. A couple of other executives sold a small number of shares earlier this month.A director added more than 9,100 Bristol-Myers Squibb Co (NYSE: BMY) shares to his stake. At a share price of $54.50, that totaled shy of $500,000, and it increased his stake by about 41%. Note that a pair of executives sold over 28,000 shares back in May.An Uber Technologies Inc (NYSE: UBER) director indirectly acquired some shares of this San Francisco-based ride-hailing company early last week. At prices ranging from $31.57 to $31.66, the more than 15,400 shares added up to about $497,400.See also: Why Sonos Stock Is Trading Lower TodayA smaller amount of insider buying occurred at Cooper Companies Inc (NYSE: COO), Enterprise Products Partners L.P. (NYSE: EPD), Park Hotels & Resorts Inc (NYSE: PK), Truist Financial Corp (NYSE: TFC) and VF Corp (NYSE: VFC). At the time of this writing, the author had no position in the mentioned equities.Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.See more from Benzinga * Barron's Picks And Pans: Brunswick, Cloudflare, Gilead And More * Bulls And Bears Of The Week: Apple, Oracle, US Steel And More * Barron's Picks And Pans: Chevron, Goldman Sachs, Progressive And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The largest Insider Buys this week were for Bristol-Myers Squibb Company, Cigna Corp., Uber Technologies Inc. and Enterprise Products Partners LP Continue reading...
Cigna's (CI) alliance with Huntsville Hospital intends to provide improved health outcomes for the company's members under its Medicare Advantage plans.
Cigna Corporation (NYSE:CI) shareholders (or potential shareholders) will be happy to see that the Independent...
U.S. health insurers may balk at covering tests that look for coronavirus antibodies in some cases, arguing that employers or the government should foot a bill expected to run into billions of dollars. Health insurers have largely escaped the economic pain wrought by the pandemic. Now the industry is tallying up the potential cost of expanding both diagnostic and antibody testing, seen as a critically important component of safely reopening businesses across the country.
The Cigna Foundation is inviting nonprofits working to create greater access to mental health services to apply for funding through its Healthier Kids For Our FutureSM grant program. The program will provide up to a total of $5 million in grants to community organizations over the next year.
Effective immediately, global health service company Cigna (NYSE: CI) is expanding its support for customers during this unprecedented COVID-19 pandemic by eliminating cost-sharing for all primary care, specialty care and behavioral health care in-office or telehealth visits for COVID-19 and non-COVID-19 care. This expansion applies to all U.S. customers enrolled in Cigna's Medicare Advantage and Individual and Family Plans, including those sold on the Individual Marketplace. Additionally, Cigna is making enhancements to its Medicare Advantage meal plan benefits to further protect customers during this pandemic and underscore the company's continued commitment to enabling access to simple, affordable and predictable health care.
IBD Stock Of The Day: UnitedHealth broke out into a buy zone, topping its pre-coronavirus peak as managed care stocks rally. The Dow giant offers balance for a portfolio of growth stocks.
The stock market slid in afternoon trading Thursday, causing the Dow Jones Industrial Average to close with a loss.
Cigna's (NYSE:CI) International Markets business, in partnership with Kantar, today published its first Cigna COVID-19 Global Impact Study. Part of Cigna's annual 360 Well-Being Survey, this research is the first in a new series of studies from Cigna to better understand the global impact of the COVID-19 pandemic on people's well-being.